Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Melanoma Research|September 22, 2007
Clinical complete long-term remission of a patient with metastatic malignant melanoma under therapy with indisulam (E7070)Martina Baur, Margit Gneist, Takashi Owa, et al.
Current Medicinal Chemistry|April 8, 2003
Anticancer and antiviral sulfonamidesAndrea Scozzafava, Takashi Owa, Antonio Mastrolorenzo, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IXFrancesco Abbate, Angela Casini, Takashi Owa, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2012
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatmentYoichi Ozawa, Kazutomi Kusano, Takashi Owa, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 30, 2020
Enhancement of Soft Tissue Sarcoma Response to Gemcitabine through Timed Administration of a Short-Acting Anti-Angiogenic AgentJin Cheng, John Fuller, Regina Feldman, et al.
Bioorganic & Medicinal Chemistry|May 22, 2009
Chemistry of renieramycins. Part 8: synthesis and cytotoxicity evaluation of renieramycin M-jorunnamycin A analoguesKornvika Charupant, Naomi Daikuhara, Emi Saito, et al.
Biochemistry|April 26, 2006
Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferationRenu Mohan, Mithu Banerjee, Anasuya Ray, et al.
Marine Drugs|January 26, 2010
Microarray-based transcriptional profiling of renieramycin M and jorunnamycin C, isolated from Thai marine organismsKornvika Charupant, Khanit Suwanborirux, Naomi Daikuhara, et al.
Pageof 3